Should You Buy Oracle Stock While It's Down 53% From Its Peak? The Answer Might Surprise You.

Oracle's fiscal Q1 2027 cloud-infrastructure revenue surged 120% year over year to $7.4 billion, helping total revenue rise 30% to $19.3 billion, but the article argues this growth does not offset rising execution and credit risks. The company has $664 billion of remaining performance obligations, with OpenAI reportedly representing $300 billion despite only $40 billion of annualized revenue and ongoing losses. Oracle also carries more than $117 billion in long-term debt to fund AI data-center expansion, creating material downside if customers fail to meet contracted commitments. Although Oracle trades at 22.6x trailing GAAP EPS versus its five-year average of 34.6x, uncertainty over backlog conversion supports a cautious view.

Analysis

Oracle's key underwriting issue is not demand for GPU capacity but the mismatch between long-lived, debt-funded infrastructure and a concentrated set of counterparties whose funding is equity- and capital-markets-dependent. If capacity is built ahead of enforceable customer prepayments or parent guarantees, a deferral converts rapidly from a revenue issue into lower utilization, negative operating leverage, and potential refinancing/multiple compression. The market should value portions of contracted demand from sub-investment-grade AI labs closer to contingent receivables than to conventional cloud backlog.

Near term, supplier read-through remains constructive: NVDA and AMD monetize delivered accelerators before Oracle's end-customer economics are proven. Over 6-18 months, however, any Oracle capex pause would matter disproportionately for networking, power, cooling and GPU demand because it would signal that frontier-model training demand is becoming financing-constrained rather than chip-constrained. META is a relative winner if third-party capacity loosens: its balance sheet can capture lower-priced compute and it faces materially less counterparty risk than a specialized cloud lessor.

Consensus may be too focused on the headline valuation discount and insufficiently focused on cash-flow quality. A cheap earnings multiple is not a catalyst while depreciation, interest expense and committed build costs rise faster than realized utilization; conversely, verified deposits, minimum-volume commitments, or credit enhancement from strategic partners could sharply rerate the equity. The decisive disclosures are customer concentration, cancellation rights, prepayment balances, capacity commissioning dates, and incremental debt cost—not another quarter of booked demand.

Key Decisions for Investors

• Maintain an underweight ORCL for the next 1-3 months; add downside only after reviewing contract credit support and capex guidance. Use a 6-9 month put spread rather than outright puts: target 2:1 payoff if management cuts infrastructure capex or raises provisions, with thesis invalidated by disclosed customer prepayments/guarantees and sustained positive free-cash-flow conversion.
• Pair long META / short ORCL on a 6-12 month horizon. The trade isolates a potential shift from leveraged merchant compute to self-funded hyperscale demand; stop if Oracle demonstrates stable utilization and financing costs while META materially accelerates its own uneconomic capex.
• Remain tactically long NVDA versus ORCL through the next supplier earnings cycle, but treat it as a 1-3 month order-delivery trade rather than a structural Oracle read-through. Reduce if NVDA identifies broad cloud-provider order deferrals, particularly from non-hyperscale customers, since that would validate a financing-led demand slowdown.
• Set an alert for Oracle disclosures showing rising net debt, weaker operating cash flow after capex, or a gap between commissioned capacity and recognized infrastructure revenue. Any two of these signals warrant increasing the ORCL short; absent them, the article alone is insufficient evidence for an aggressive directional position.